Deep-pocketed investors have adopted a bullish approach towards DexCom DXCM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DXCM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for DexCom. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable options, 5 are puts, totaling $243,316, and 5 are calls, amounting to $151,590.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $175.0 for DexCom over the last 3 months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for DexCom's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of DexCom's whale trades within a strike price range from $120.0 to $175.0 in the last 30 days.
DexCom 30-Day Option Volume & Interest Snapshot
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DXCM | PUT | SWEEP | BULLISH | 09/20/24 | $7.4 | $7.2 | $7.4 | $125.00 | $63.6K | 23 | 0 |
| DXCM | PUT | TRADE | BEARISH | 11/15/24 | $7.3 | $7.1 | $7.3 | $120.00 | $58.4K | 56 | 235 |
| DXCM | PUT | TRADE | BEARISH | 01/17/25 | $17.5 | $17.2 | $17.5 | $140.00 | $52.5K | 135 | 109 |
| DXCM | PUT | SWEEP | BEARISH | 09/20/24 | $5.4 | $5.3 | $5.4 | $120.00 | $42.6K | 186 | 1 |
| DXCM | CALL | SWEEP | BULLISH | 01/17/25 | $9.8 | $9.6 | $9.8 | $175.00 | $34.3K | 517 | 37 |
About DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Where Is DexCom Standing Right Now?
- Trading volume stands at 2,057,557, with DXCM's price down by -0.5%, positioned at $139.62.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 14 days.
What Analysts Are Saying About DexCom
In the last month, 2 experts released ratings on this stock with an average target price of $162.0.
- Maintaining their stance, an analyst from UBS continues to hold a Buy rating for DexCom, targeting a price of $163.
- Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on DexCom with a target price of $161.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DexCom, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
